In a stunning announcement that has sparked global curiosity, Chinese biotech company Lonvi Biosciences claims to have developed a grape-seed extract capsule that could potentially extend human life expectancy to 150 years.
According to the firm, the capsule harnesses the antioxidant properties of grape seeds to repair cellular damage, slow down aging, and boost overall longevity — positioning it as one of the most ambitious anti-aging breakthroughs in modern science.
The announcement comes amid China’s growing investment in biotechnology and longevity research, which has now become a national priority alongside artificial intelligence (AI) and digital innovation.
However, scientists and medical experts have urged caution, noting that the claim remains unverified and lacks peer-reviewed evidence. They warn that, while promising, such lifespan-extension assertions should be treated with skepticism until supported by rigorous scientific validation.
If proven true, the discovery could redefine the future of medicine, health, and aging — but for now, the world is watching and waiting for solid scientific proof.
